hh.sePublications
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A Recent Crisis in Regenerative Medicine: Analyzing Governance in Order to Identify Public Policy Issues
Institute for Innovation and Entrepreneurship, School of Business, Economics and Law, University of Gothenburg, Gothenburg, Sweden.
Halmstad University, School of Business, Engineering and Science, Centre for Innovation, Entrepreneurship and Learning Research (CIEL).ORCID iD: 0000-0002-8563-9078
Institute for Innovation and Entrepreneurship, School of Business, Economics and Law, University of Gothenburg, Gothenburg, Sweden.
2018 (English)In: Science and Public Policy, ISSN 0302-3427, E-ISSN 1471-5430, Vol. 45, no 5, p. 608-620Article in journal (Refereed) Published
Abstract [en]

This article focuses upon issues that public policy makers need to address, when trying to stimulate world-leading research into new areas, which are potentially also valuable to solving societal challenges. Our analysis helps contribute to the theoretical discussions about governance of new knowledge. We focus upon the sequence of events surrounding the main actors of a recent crisis of regenerative medicine in Sweden. We define governance theoretically, and use a conceptual model in order to structure the empirical analysis. Regenerative medicine is an interesting setting to explore these topics, not least because both public and private actors are often involved, and because governments struggle with how to promote ‘translational research’, e.g. diffusing scientific research into clinical practice. Our case study helps understand the process that led up to a crisis in regenerative medicine and identifies and discusses four issues that need to be addressed by policy makers. © The Author(s) 2018. Published by Oxford University Press.

Place, publisher, year, edition, pages
Oxford: Oxford University Press, 2018. Vol. 45, no 5, p. 608-620
Keywords [en]
innovation policy, governance, medical research and innovation
National Category
Economics and Business
Identifiers
URN: urn:nbn:se:hh:diva-38627DOI: 10.1093/scipol/scx085OAI: oai:DiVA.org:hh-38627DiVA, id: diva2:1271229
Available from: 2018-12-17 Created: 2018-12-17 Last updated: 2018-12-17Bibliographically approved

Open Access in DiVA

fulltext(361 kB)7 downloads
File information
File name FULLTEXT01.pdfFile size 361 kBChecksum
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Saemundsson, Rögnvaldur

Search in DiVA

By author/editor
Saemundsson, Rögnvaldur
By organisation
Centre for Innovation, Entrepreneurship and Learning Research (CIEL)
In the same journal
Science and Public Policy
Economics and Business

Search outside of DiVA

GoogleGoogle Scholar
Total: 7 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf